High-Throughput Screening (HTS) Market Size & Share, by Products & Services (Consumables, Instruments, Software, Services); Technology (Cell-Based Assays, Lab-on-a-Chip Technology, Label-Free Technology); Application (Target Identification & Validation, Primary & Secondary Screening); End-user (Pharmaceutical & Biotechnology Firms, Academia & Research Institutes) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 3521
  • Published Date: Apr 13, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2023-2035

High-Throughput Screening (HTS) Market size is estimated to reach USD 47 Billion by the end of 2035, growing at a CAGR of 11% during the forecast period, i.e., 2023-2035. In the year 2022, the industry size of high-throughput screening was over USD 19 Billion. The growth of the market can be attributed to the growing demand for stem cell therapy. The increased incidence of chronic illnesses across the globe is rising the need for stem cell treatment. Further, researchers frequently utilize high-throughput screening (HTS) of stem cells to better understand the fundamental mechanisms governing stem cell destiny, which is also expected to add to the market growth. Over 20% of New York individuals have a chronic illness, and more than 22% of all hospitalizations in the state are brought on by these conditions.

In addition to these, factors that are believed to fuel the market growth of high-throughput screening (HTS) include the increasing number of drug targets being employed for screening. The identification of a novel therapeutic target is frequently the initial step in the research and development of medications. For instance, in drug development, phenotypic screening is a method for finding compounds that can change a cell's phenotype. Additionally, the increasing investments by the government and research institutes to develop new products are predicted to present the potential for market expansion over the projected period.


High-Throughput Screening (HTS) Market
Get more information on this report: Request Free Sample PDF

High-Throughput Screening (HTS) Sector: Growth Drivers and Challenges

Growth Drivers

  • Growing Demand for Drugs– On account of the increasing prevalence of chronic disorders across the globe has increased the demand for medicines for treatment. Further, the growing use of HTS for the drug development process is estimated to drive market growth. The number of drug users worldwide is expected to increase by over 10% by 2030.

  • Rising Geriatric Population – Owing to a weak immune system elderly population is more prone to various diseases such as dementia, high blood pressure, and diabetes, which is estimated to drive market growth. As of 2021, the elderly population in India is predicted to increase by over 9%.

  • Increasing Health Spending – Increased government programs and investments in medication research, are anticipated to drive the market growth According to the most recent expenditure data, in 2020, health spending in the US rose by over 9%.

  • Growing Pharmaceutical and Biotechnology Sectors – It is expected that the growing launch of new and advanced drugs, and strong investment in the biotech and pharmaceutical industries, are anticipated to drive market growth. According to estimates, the biotechnology sector in India has grown to a value of over USD 80 billion in 2022.

Challenges

  • Difficulties in Assay Development – To create secondary assays, HTS goes through several difficult stages. It is more costly since the complexity of the assay affects both the time and cost, as a result, it is less adopted by some academic research laboratories.
  • Exorbitant Cost of HTS Instruments– High maintenance costs, and other indirect expenses, increase the total cost of HTS instruments, which is one of the major factors predicted to slow down the market growth.
  • Need for a Large Capital Investment
  • Lack of Skilled Professionals

High-Throughput Screening (HTS) Market: Key Insights

Base Year

2022

Forecast Year

2023-2035

CAGR

~11%

Base Year Market Size (2022)

~ USD 19 Billion

Forecast Year Market Size (2035)

~ USD 47 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

High-Throughput Screening (HTS) Segmentation

Products & Services (Consumables, Instruments, Software, Services)

The global high-throughput screening (HTS) market is segmented and analyzed for demand and supply by-products into consumables, instruments, software, and services. Out of the four products, the consumables segment is estimated to gain the largest market share over the projected time frame. The growth of the segment can be attributed to the increasing demand for new and advanced drugs. The adoption of HTS for developing new drugs is anticipated to create numerous opportunities for the growth of the segment. For instance, microplates, pipette tips, and assay plates are consumables that are essential to the HTS workflow. In addition, improvements in HTS technology that enable more intricate and varied screening trials rises the demand for consumables. Furthermore, the need for specialized consumables will probably increase as HTS technologies develop further. By 2026, over 200 new medications are anticipated to be released across the globe.

End-user (Pharmaceutical & Biotechnology Firms, Academia & Research Institutes)

The global high-throughput screening (HTS) market is also segmented and analyzed for demand and supply by end-user into pharmaceutical & biotechnology firms, academia & research institutes, and contract research organizations. Amongst these three segments, the pharmaceutical & biotechnology firms segment is expected to garner a significant share. The growth can be attributed to the increasing creation of new compounds to cure many chronic diseases. High-throughput screening (HTS) is widely used in the pharmaceutical and biotechnology industries to find new drugs. Further, the drug development process has been transformed by HTS technology, which allows scientists to quickly screen millions of molecules. As a result, several novel medications have been created to treat a variety of illnesses and ailments, such as cancer, cardiovascular, and infectious diseases. This, as a result, is anticipated to create numerous opportunities for the growth of the segment in the coming years.

Our in-depth analysis of the global market includes the following segments:

         By Products & Services

  • Consumables
  • Instruments
  • Software
  •  Services

        By Technology

  • Cell-Based Assays
  • Lab-on-a-Chip Technology
  • Label-Free Technology

       By Application

  • Target Identification & Validation
  • Primary & Secondary Screening
  • Toxicology Assessment
  •  Others

        By End User

  • Pharmaceutical & Biotechnology Firms
  • Academia & Research Institutes
  • Contract Research Organizations

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

High-Throughput Screening (HTS) Industry - Regional Synopsis

North American Market Forecast

The North American high-throughput screening (HTS) market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2035. The growth of the market can be attributed majorly to the growing pharmaceutical industry owing to the rise in chronic illnesses in the region. The creation and manufacture of new and unique drugs for a variety of life-threatening illnesses such as cancer, cardiovascular disorders, metabolic disorders, immunological disorders, and neurological disorders are a focus of both large and small pharmaceutical businesses in the region. This as result will rise the demand for high throughput screening as it is required for screening novel chemical entities with more efficiency. Further, the rising investment in R&D by pharmaceutical and biotechnology, and increasing technological developments in high-throughput screening (HTS), are also anticipated to contribute to the market growth in the region. Almost half of adult Americans suffer from chronic illnesses, which accounts for over 60% of all fatalities in the United States.

APAC Market Statistics

The Asian Pacific high-throughput screening (HTS) market, amongst the market in all the other regions, is projected to grow with the highest CAGR during the forecast period. The growth of the market can be attributed majorly to the growing cases of chronic diseases in the region. The main causes of mortality and disability in the area are chronic illnesses including diabetes, cancer, heart disease like heart attack, and many more, caused by the growing usage of tobacco and being around smoke. The usage of medicine is one of the most popular techniques to manage chronic illness. The use of HTS in the drug development process allows for the subsequent identification of candidates for the treatment of chronic illnesses including cancer, HIV, and cardiovascular ailments, which is anticipated to contribute to the market growth in the region. In addition, the region's growing healthcare industry and adoption of innovative technology to raise the quality of medication, are also anticipated to boost the market growth during the forecast period. By 2045 India is predicted to have over 130 million people with diabetes.

Europe Market Forecast

Further, the market in Europe, amongst the market in all the other regions, is projected to hold a majority of the share by the end of 2035. The growth of the market can be attributed majorly to the growing technologically advanced products in the high throughput screening. For instance, the pharmaceutical and biotech sectors have a significant interest in using AI in HTS. The majority of the biggest biopharmaceutical firms in the region are working together to build AI platforms for enhancing the research capacity of immuno-oncology medications, metabolic disease medicines, cancer treatments, and many other therapeutic targets. In addition, high-throughput screening is also in higher demand since it is necessary to screen novel chemical entities, which in turn is anticipated to contribute to the market growth in the region.

Research Nester
High-Throughput Screening (HTS) Market Size
Get more information on this report: Request Free Sample PDF

Companies Dominating the High-Throughput Screening (HTS) Landscape

top-features-companies
    • Carna Biosciences, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Agilent Technologies, Inc.,
    • Thermo Fisher Scientific
    •  Tecan Trading AG
    • Promega Corporation
    • Hamilton Company
    • BPS Bioscience, Inc.
    • PerkinElmer Inc.
    • Merck KGaA

In the News

  • PerkinElmer Inc. introduced EnVision Nexus system, which enables researchers to screen millions of samples with greater accuracy, speed, and sensitivity. Further, it is developed for demanding high-throughput screening (HTS) applications and to speed up drug development efforts.

  • Thermo Fisher Scientific teamed up with Celltrio to introduce a fully automated cell culture system. The collaboration will fill a major need in the market for high-throughput automated cell line culture and maintenance.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 3521
  • Published Date: Apr 13, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing demand for drugs, and the rising geriatric population are the major factors driving the market growth.

The market is anticipated to attain a CAGR of ~11% over the forecast period, i.e., 2023-2035.

Need for a large capital investment, and a lack of skilled professionals are estimated to be the growth-hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Agilent Technologies, Inc., Thermo Fisher Scientific, Tecan Trading AG, Promega Corporation, Hamilton Company, BPS Bioscience, Inc., PerkinElmer Inc., Merck KGaA, and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by products & services, technology, application, end-user, and by region.

The consumables segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
High-Throughput Screening Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying